| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.007 |